Urine Pentamidine as an Indicator of Lung Pentamidine in Patients Receiving Aerosol Therapy
- 1 November 1991
- Vol. 100 (5) , 1219-1223
- https://doi.org/10.1378/chest.100.5.1219
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Factors Determining Pulmonary Deposition of Aerosolized Pentamidine in Patients with Human Immunodeficiency Virus InfectionAmerican Review of Respiratory Disease, 1991
- Aerosolized Pentamidine for Prophylaxis againstPneumocystis cariniiPneumoniaNew England Journal of Medicine, 1990
- Inhaled or Intravenous Pentamidine Therapy for Pneumocystis carinii Pneumonia in AIDSAnnals of Internal Medicine, 1990
- Aerosolized Pentamidine: Effect on Diagnosis and Presentation of Pneumocystis carinii PneumoniaAnnals of Internal Medicine, 1990
- Inhaled PentamidineDrugs, 1990
- PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA BY INHALED PENTAMIDINEThe Lancet, 1989
- Concentrations of aerosolized pentamidine in bronchoalveolar lavage, systemic absorption, and excretionAntimicrobial Agents and Chemotherapy, 1988
- AEROSOLISED PENTAMIDINE AS SOLE THERAPY FOR PNEUMOCYSTIS CARINII PNEUMONIA IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROMEThe Lancet, 1987
- Use of a Specific and Sensitive Assay to Determine Pentamidine Pharmacokinetics in Patients with AIDSThe Journal of Infectious Diseases, 1986